Clinical Trial Update: Bioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combination With Cobicistat [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing separate atazanavir and cobicistat with the fixed-dose combination of atazanavir/cobicistat in HIV infection. The trial i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• REYATAZ (atazanavir)
• Tybost (Cobicistat)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Human Immunodeficiency Virus Type 1 (HIV-1) | Phase 1 | Status: COMPLETED | Results posted: 2014-08-29